Altria and Philip Morris International Stocks Affected By Vaping Situation

As the public scrutiny over e-cigarettes, vaping and underage use of these products increases, the impact on shares and performances of some of the tobacco industry’s biggest players continues to be discussed by analysts and financial markets.

At the Food and Drug Law Institute (FDLI) Tobacco & Nicotine Products Regulation & Policy Conference in Washington, D.C. Oct. 24-25, 2019, vaping and its impact on public health was a major topic of discussion and focus. There’s a clear divide between the industry and the government over vaping, with the U.S. Food and Drug Administration’s (FDA) possible flavored e-cigarette ban making many manufacturers and investors worried about the future of vaping and e-cigarette products and usage in the U.S.

Continue Reading On: Tobacco Business Magazine